Article
Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
1 Apr 2021
Abstract excerpt
BACKGROUND: Hepatocellular carcinoma (HCC) ranks the sixth prevalent tumors with high mortality globally. Alternative splicing (AS) drives protein diversity, the imbalance of which might act an important factor in tumorigenesis. This study aimed to construct of AS-based prognostic signature and elucidate the role in tumor immune microenvironment (TIME) and immunotherapy in HCC. METHODS: Univariate Cox regression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
